Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Catherine Tomlinson unpacks why these new antibiotics are important and what needs to happen before they can be used in South Africa.
Several studies have flagged problems with South Africa’s death registration processes. A critical first step to addressing it is to replace our paper-based process with an electronic one, argue Dr Pam Groenewald and Professor Debbie Bradshaw, both of the SAMRC’s Burden of Disease Research Unit.
The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used in some other countries, but has not yet been registered in South Africa, though it can be obtained by those with money who are willing to jump through some hoops. Catherine Tomlinson reports.
Massive gains have been made in reducing new HIV infections and deaths in children. Yet, many of the statistics for children still look worse than those for adults. Elri Voigt asked experts why this is the case and what factors prevent children living with HIV from starting and staying on the treatment that can keep them healthy.
Minister of Health Dr Aaron Motsoaledi’s recent claim that over half a million people have been newly started on HIV treatment in less than six months has raised eyebrows in health circles. In this open letter, Anna Grimsrud and Sibongile Tshabalala-Madhlala, associated with CHANGE – South Africa, ask the Minister to explain numbers that, on the face of it, seem contradictory.
Groote Schuur Hospital’s first male nursing manager, Aghmat Mohamed, reflects on the pressures of nursing in South Africa. Ahead of International Nurses Day and the release of a major global report on the state of nursing, Biénne Huisman chatted to him about his decades on the front lines of healthcare.
Over the last two decades, South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the right puzzle pieces for prevention but failing to integrate them optimally. Elna Schütz reports.
The Special Tribunal has ordered four ambulance companies run by Thapelo Buthelezi to pay back a total of over half-a-billion rand. The matter relates to contracts awarded by the Free State government, which were first reported on in Spotlight’s #Health4Sale series of investigative articles in 2018.
Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.
US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
Trade unions, medical associations and universities are raising the alarm that Gauteng budget cuts at the cost of doctors’ take-home pay will have dire consequences for public sector health. Meanwhile, the National Minister of Health has convened a committee to review the future of overtime for state doctors. Ufrieda Ho reports.
There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.
